Physician

Ahmed Fawzy, MD

According to 2025 Medicare claims, Ahmed Fawzy, MD (NPI: 1700861358) practices urology in the Ithaca, NY market, with the plurality of this provider's patient population coming from Tompkins, NY. This provider's primary affiliated billing organization is GUTHRIE MEDICAL GROUP, P.C. (NPI: 1134178635; TIN: 250815795) and primary practice location at 14850-3215. Fawzy is affiliated with the Humana Direct Contracting Entity, Inc. (ACO ID: D0203), participating under the REACH model.

Fawzy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 126 traditional Medicare patients, billed 346 HCPCS/CPT codes, and received $23,062 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 324 prescription claims across 143 beneficiaries totaling $48,906 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). 2023 DME data shows 12 claims. Open Payments data shows 2 records totaling $122. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $144,513 to $23,062. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $44,338 and ending at $48,906. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $435 to $535.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	635	2,135	$144,513
2016	570	2,215	$115,870
2017	604	2,164	$175,859
2018	607	2,396	$143,458
2019	533	3,500	$135,190
2020	437	3,695	$105,345
2021	447	2,681	$102,467
2022	362	982	$75,690
2023	223	846	$42,781
2024	126	346	$23,062

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	358	889	$44,338
2016	344	947	$37,889
2017	398	1,062	$44,304
2018	398	1,162	$54,346
2019	373	1,060	$33,459
2020	344	1,045	$27,559
2021	360	1,118	$56,533
2022	341	939	$201,277
2023	240	706	$131,206
2024	143	324	$48,906

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	75	$5,968
2016	89	263	$6,786
2017	69	140	$4,026
2018	75	129	$1,179
2019	42	80	$853
2020	52	67	$707
2021	33	65	$535
2022	N/R	29	$485
2023	N/R	12	$131
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	11	11	$127
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	40	44	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	23	25	$67
36415	Insertion of needle into vein for collection of blood sample	29	35	$9
51798	Ultrasound measurement of bladder capacity after voiding	39	40	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	146	10,017	$2,219
Finasteride	Finasteride	25	1,982	$466
Oxybutynin Chloride Er	Oxybutynin Chloride	24	1,380	$367
Cephalexin	Cephalexin	45	100	$69
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	128	$21

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$122	PROCEPT BioRobotics Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmed Fawzy, MD?

Tedicare shows public-source Medicare data for Ahmed Fawzy, MD (NPI 1700861358), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Fawzy, MD have ACO affiliation data?

Ahmed Fawzy, MD is shown with ACO affiliation data for Humana Direct Contracting Entity, Inc. (REACH, ACO ID D0203).

What billing organization is linked to Ahmed Fawzy, MD?

Ahmed Fawzy, MD is linked to GUTHRIE MEDICAL GROUP, P.C. (billing NPI 1134178635) in the available physician profile data.

Does Ahmed Fawzy, MD have Open Payments data?

Ahmed Fawzy, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.